- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 309/14 - Nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 309/14
Total number of patents in this class: 381
10-year publication summary
|
39
|
25
|
26
|
20
|
23
|
20
|
21
|
25
|
14
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4811 |
13 |
| Pfizer Inc. | 3367 |
12 |
| Corteva Agriscience LLC | 2643 |
11 |
| Pro Farm Group, Inc. | 124 |
10 |
| Takeda Pharmaceutical Company Limited | 2718 |
9 |
| The Regents of the University of California | 20574 |
7 |
| Abbvie Inc. | 1842 |
7 |
| Purdue Research Foundation | 3856 |
6 |
| Dart NeuroScience, LLC | 50 |
5 |
| Fondazione Istituto Italiano di Tecnologia | 616 |
5 |
| Oryzon Genomics S.A. | 102 |
5 |
| Taisho Pharmaceutical Co., Ltd. | 858 |
5 |
| Suzhou Abogen Biosciences Co., Ltd. | 75 |
5 |
| Board of Regents, The University of Texas System | 6050 |
4 |
| Hangzhou DAC Biotech Co., Ltd | 109 |
4 |
| Tianjin Chasesun Pharmaceutical Co., Ltd | 13 |
4 |
| The University of British Columbia | 1531 |
4 |
| Neuprozyme Therapeutics ApS | 4 |
4 |
| Lhotse bio, Inc. | 11 |
4 |
| F. Hoffmann-La Roche AG | 7837 |
3 |
| Other owners | 254 |